Detalhe da pesquisa
1.
Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
Altern Ther Health Med
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581330
2.
Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.
BMC Urol
; 18(1): 82, 2018 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249226
3.
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Tumour Biol
; 39(6): 1010428317703924, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651494
4.
Hue-Preserving Saturation Improvement in RGB Color Cube.
J Imaging
; 7(8)2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460786
5.
Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.
Front Genet
; 12: 703210, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34484299
6.
LncRNA growth arrest-specific transcript 5 targets miR-21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN.
Cancer Med
; 9(8): 2846-2858, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32069387
7.
Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation.
Oncotarget
; 8(46): 80295-80302, 2017 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113303